Skip to content

Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure

Automated Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04374734
Enrollment
100
Registered
2020-05-05
Start date
2020-04-05
Completion date
2020-06-30
Last updated
2021-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS (Severe Acute Respiratory Syndrome)

Keywords

SARS, Severe Acute Respiratory Syndrome, Automated quantification, Lung volume, Thorax imaging

Brief summary

Acute respiratory failure (ARF) is a common condition and a common reason for urgent medical consultation. Assessing the extent of respiratory impairment is important to improve the management of patients with ARF. When Acute respiratory failure is caused by pathology of the pulmonary parenchyma, quantification of pulmonary radiographic involvement may be a component of the initial assessment of severity. This radiographic quantification would only be usable in clinical routine if it can be automated and provide a real-time result. The objective of this work is to assess the feasibility of an automated technique for quantifying radiological lung damage in situations of known or potential ARF.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients over 18 years of age * Presenting a situation at risk of acute respiratory failure * Requiring thorax imaging when they were treated.

Exclusion criteria

* Patients with anatomically incomplete thoracic imaging (e.g., technical acquisition error).

Design outcomes

Primary

MeasureTime frame
Retrospective study of the relationship between severe forms of ARF and the extent of lung involvement2 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026